Prediction: Upstart Will Soar in 2026

Upstart (NASDAQ: UPST) is trading more than 50% below its 52-week high (prices cited as of the morning of Jan 29, 2026) after recent earnings reports that raised legitimate concerns about the business and outlook. In a Jan 30, 2026 video the author argues the shares could rally 50%+ by 2026, a bullish yet speculative take reinforced by disclosures that the author and The Motley Fool hold/recommend the stock.

Analysis

Market structure: Upstart (UPST) underperformance is re-pricing risk in AI-driven consumer lending — winners include cash-rich banks and ABS buyers who can pick up originations at wider spreads, losers are small fintech originators without funding diversity. If UPST loses distribution or its take-rates compress, incumbents regain pricing power; conversely, a Fed easing in H2 2026 would lift unsecured demand and ABS issuance, tightening funding spreads by ~50–150bps. Cross-asset: higher perceived credit risk pushes ABS spreads wider and increases single-name equity implied vol; expect short-term bond spread widening and elevated equity option IV for UPST and peers.

Risk assessment: Tail risks are regulatory (CFPB/DOJ fair-lending review), model failure (systematic bias leading to higher charge-offs), or funding shock if the securitization market freezes — each can wipe out >50% equity value. Immediate risk (days) is earnings-driven IV spikes; short-term (weeks–months) is Q1 loan seasoning; long-term (12–24 months) depends on net charge-off trajectory and capital access. Hidden dependency: ~30–50% of originations rely on partner banks and third-party capital — concentration here is a second-order liquidity lever.

Trade implications: Construct small, conditional exposure — size bets to outcome: if next two quarters show stabilizing net charge-offs (month-over-month decline of >50bps) and renewed ABS issuance, UPST equity can re-rate +40–60% into 2026. Tactical option play: buy 9–12 month call spreads to cap cost if you expect Fed cuts; hedge with 1–3 month put spreads around earnings. Rotate 2–4% weight from high-beta consumer lenders into short-duration investment-grade credit and ABS managers until credit curves normalize.

Contrarian angles: Consensus focuses on charge-offs but underweights the ability to re-source capital via ABS and bank partners — historical parallels (post-2016 fintech drawdowns) show 6–12 month recoveries when capital returns. The selloff may be overshooting if UPST posts sequential loss improvement of 25–50bps; downside remains if regulators limit algorithmic underwriting, an outcome that would structurally impair their moat.

Key Decisions for Investors

• Establish a tactical long position in UPST sized 1.5–3% of equity portfolio only after sizing conviction: scale-in over 2–4 tranches if next two monthly loss metrics show sequential improvement ≥25bps; set a hard stop at -25% from entry or on any formal CFPB/DOJ action.
• Pair trade: Go long UPST (1–2% portfolio) and short AFRM (Affirm) equal-dollar (1–2%) to express a long relative-play on superior credit performance; unwind after 6–12 months or if the pair diverges >25% in either direction.
• Options hedge: Buy a 3-month put spread (buy ~30-delta, sell ~15-delta) sized to cover 50% of your UPST position through the next earnings; concurrently buy a 9–15 month call spread (buy LEAP ~30% OTM, sell ~15% OTM) to retain upside with defined cost.
• Reallocate 2–4% from high-beta consumer finance equities into short-duration IG credit/ABS exposure (e.g., VCSH or ABS-focused managers) until ABS spreads compress by >75bps or securitization issuance visibly resumes (track monthly ABS issuance data and NAREIT-style securitization calendars).